Inflammatory myopathy with cytochrome oxidase negative muscle fibers: Methotrexate treatment

Muscle and Nerve

Volumn 21, Issue 12, 1998, Pages 1724-1728

  Levine, Todd D ^a   Pestronk, Alan ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immune; Inflammatory myopathy; Methotrexate; Mitochondria; Myositis

Indexed keywords

CYTOCHROME C OXIDASE; METHOTREXATE;

ARTICLE; CELL INFILTRATION; HUMAN; HUMAN TISSUE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; MYOSITIS; PRIORITY JOURNAL;

AGED; ELECTRON TRANSPORT COMPLEX IV; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOSITIS; MYOSITIS, INCLUSION BODY; TREATMENT OUTCOME;

EID: 0031762747     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199812)21:12<1724::AID-MUS15>3.0.CO;2-2     Document Type: Article

References (16)

1. Amato AA, Gronseth GS, Jackson CE, Wolfe GI, Katz JS, Bryan WW, Barohn RJ: Inclusion body myositis - clinical and pathological boundaries. Ann Neurol 1996;40:581-586.
2. Blume G, Pestronk A, Frank B, Johns DR: Polymyositis with cytochrome oxidase negative muscle fibers: early quadriceps weakness and poor response to immunosuppressive therapy. Brain 1997;120:39-45.
3. Carpenter S, Karpati G, Heller I, Eisen A: Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology 1978;28:8-17.
4. Cronstein BN: Molecular therapeutics: methotrexate and its mechanism of action. Arthritis Rheum 1996;39:1951-1960.
5. Harding AE: Growing old: the most common mitochondrial disease of all? Nat Genet 1992;2:251-252.
6. Hassell A, Dawe P: Serious problems with methotrexate? Br J Rheumatol 1992;33:1001-1006.
7. Joffe HH, Love LA, Leff RC, Fraser DD, Targoff LN, Kicks JE, Plotz PH, Miller FW: Drug therapy of the idiopathic inflammatory myopathies. Am J Med 1993;94:379-387.
8. Mastaglia FL, Phillips BA, Zilko P: Treatment of inflammatory myopathies. Muscle Nerve 1997;20:651-664.
9. Oldfors A, Larsson NG, Lindberg C, Holme E: Mitochondrial DNA deletion in inclusion body myositis. Brain 1993;116: 325-336.
10. Oldfors A, Moslemi AR, Fyhr IM, Holme E, Larsson NG, Lindberg C: Mitochondrial DNA deletions in muscle fibers in inclusion body myositis. J Neuropathol Exp Neurol 1995;54: 581-587.
11. Pestronk A, Lopate G, Kornberg AJ, Elliott JL, Blume G, Yee WC: Distal lower motor neuron syndrome with high titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide. Neurology 1994;44:2027-2031.
12. Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME: Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 1989;111:143-157.
13. Rifai Z, Welle S, Kamp C, Thornton CA: Ragged red fibers in normal aging and inflammatory myopathy. Ann Neurol 1995; 37:24-29.
14. Sivakumar K, Dalakas MC: Inclusion body myositis and myopathies. Curr Opin Neurol 1997;10:413-420.
15. Weinblatt ME: Methotrexate for chronic diseases in adults. N Engl J Med 1995;332:330-331.
16. Weinblatt ME, Maier AL, Fraser PA, Coblyn JS: Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy. J Rheumatol 1998;25: 238-242.